F19.280
Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F19.280 refers to a condition where an individual is dependent on psychoactive substances and experiences anxiety disorders induced by their substance use. This diagnosis highlights the complex relationship between substance dependency and mental health issues, specifically how the use of certain substances can trigger anxiety symptoms. Recognizing this condition is essential for healthcare providers to develop comprehensive treatment plans that address both substance dependence and associated mental health challenges.
Causes & Symptoms
Clinical Causes: Chronic use of psychoactive substances such as alcohol, stimulants, opioids, or sedatives Genetic predisposition to addiction or anxiety disorders Psychosocial factors including stress, trauma, or environmental influences Insufficient mental health support leading to self-medication with substances Co-occurring psychiatric conditions that increase vulnerability to substance dependence
Key Symptoms: Persistent dependence on psychoactive substances Anxiety symptoms like restlessness, rapid heartbeat, sweating, or feeling tense Craving the substance to relieve anxiety or distress Difficulty controlling or stopping substance use despite negative effects Physical signs of substance use such as tremors, dilated pupils, or poor coordination Changes in mood, sleep disturbances, or irritability linked to substance consumption
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough clinical assessment, including a detailed history of substance use and mental health symptoms. Healthcare providers may use standardized questionnaires or screening tools to evaluate dependency levels and the presence of anxiety disorders. Laboratory tests or laboratory-based screenings may also be conducted to confirm substance use. The diagnosis aligns with clinical criteria indicating psychoactive substance dependence along with evidence of substance-induced anxiety disorder.
Treatment Protocols: Effective management typically requires a multifaceted approach, focusing on both substance dependence and anxiety symptoms. Treatment options may include:
Clinical Advice & FAQs
Billing Guidance
Is F19.280 a billable ICD-10 code?
Yes, F19.280 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.280?
Clinical documentation must specify the nature of Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference